(Q72778547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Comparative study of available medical therapy for hypercalcemia of malignancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

G. R. Mundy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6219578

31 August 2023

R. Wilkinson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6219578

31 August 2023

D. A. Heath

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6219578

31 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6219578

31 August 2023

publication date

1 March 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:0002934383909610?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

https://api.elsevier.com/content/article/PII:0002934383909610?httpAccept=text/plain

31 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

American Journal of Medicine

31 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

421-432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

Drugs for disorders of bone: pharmacological and clinical considerations

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

31 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

31 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

31 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism

31 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Metabolic Effects of Diphosphonate in Primary Hyperparathyroidism

31 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

31 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidism

31 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised r

31 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Letter: Acute hyperphosphatemia and acute persistent renal insufficiency induced by oral phosphate therapy

31 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Massive extraskeletal calcification during phosphate treatment of hypercalcemia

31 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Inhibition of parathyroid hormone stimulated bone resorption in vitro by the antibiotic mithramycin

31 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Induction of bone resorption in tissue culture. Prolonged response after brief exposure to parathyroid hormone or 25-hydroxycholecalciferol

31 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Effect of glucocorticoids on bone resorption in tissue culture

31 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Some problems of hyperparathyroidism.

31 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy

31 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy

31 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Direct resorption of bone by human breast cancer cells in vitro

31 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer

31 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit

31 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer

31 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Elevated Prostaglandins and Suppressed Parathyroid Hormone Associated with Hypercalcemia and Renal Cell Carcinoma

31 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell Adenocarcinoma

31 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors

31 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90961-0

31 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6219578%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference